Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:16:36.499Z.
Consensus retrieved: 2026-10-06T11:12:10.671Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:16:36.499Z.
Quote observation: 2026-10-06T19:15:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c1a6838803f42d6ea125a2cca62df7e150df7eb7d5f2d1fff74d5c1a91b3d340
Forward PE Ratio (N/A) = Dated Quote Price ($7.38) / Consensus Forward EPS ($-0.05)
FORWARD PE RATIO
N/A
Evolus, Inc.
Market Cap
$486.01M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Evolus, Inc. (EOLS) | $486.01M | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.34M | 25.14 |
| Oculis Holding AG (OCS)vs › | $493.37M | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.03M | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.40M | N/A |
| Arvinas, Inc. (ARVN)vs › | $472.76M | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $499.51M | 19.83 |
| Alpha Teknova, Inc. (TKNO)vs › | $471.70M | N/A |
| Kamada Ltd. (KMDA)vs › | $470.29M | 17.07 |
| Sight Sciences, Inc. (SGHT)vs › | $469.70M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $7.38, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.05 | $-0.05 – $-0.05 | 3 | n/m |
| 2027-12-31 | $0.26 | $0.21 – $0.30 | 3 | 28.9x |
| 2028-12-31 | $0.60 | $-0.37 – $1.10 | 5 | 12.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
